ALS Therapies and Treatment Updates: Updates on PrimeC by Mr.Alon Ben-Noon

Mr.Alon Ben-Noon is the Co-Founder and CEO of NeuroSense Therapeutics.
Mr Alon Ben-Noon is a Life Science Executive who prior to the establishment of NeuroSense, founded MediCan Consulting, a successful consultancy firm with clients from diversified biotech companies, and mainly in the neurodegenerative space. MediCan excelled at executing efficient, accurate, and innovative drug development programs for its clients. Prior to that, Alon worked at Teva and Perrigo.
Join ALS research
www.everythingals.org/research